Brimonidine in Rosacea
NCT05401422 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2022-06-02
Summary
Rosacea is a chronic and relapsing inflammatory cutaneous disorder with highly variable prevalence worldwide.
Conditions
- Rosacea
Interventions
- OTHER
-
treatment
types
Sponsors & Collaborators
-
Cairo University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-25
- Primary Completion
- 2022-09-15
- Completion
- 2022-09-15
More Related Trials
-
Evaluation of the Efficacy and Tolerance of Two Cosmetic Products in Subjects With Rosacea
NCT06582043 ·Status: COMPLETED ·Phase: NA
-
Pulsed Dye Laser and Intense Pulsed Light Configured With Different Wavelength Bands in Improving Erythematotelangiectatic Rosacea
NCT05360251 ·Status: UNKNOWN ·Phase: NA
-
Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study
NCT02147691 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Low-Dose Isotretenion and Long-Pulsed 1064 ND-YAG Laser in the Treatment of Acne Erythema
NCT05622253 ·Status: COMPLETED ·Phase: NA
-
Mirvaso® Gel and Dysport® for Erythema and Flushing of Rosacea
NCT03508869 ·Status: TERMINATED ·Phase: NA
-
Comparative Study of Low-Energy 1064nm Laser and DPL in Rosacea Treatment
NCT06915636 ·Status: COMPLETED ·Phase: NA
-
Potassium Titanyl Phosphate Laser Versus Pulsed Dye Laser for Rosacea - a Prospective Study
NCT05771298 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
NCT02131636 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea
NCT01579084 ·Status: COMPLETED ·Phase: PHASE1
-
RosaC-RF : Bipolar Radiofrequency vs Doxycycline in Rosacea
NCT02204254 ·Status: COMPLETED ·Phase: NA
-
DMT210 Topical Gel in the Treatment of Acne Rosacea
NCT03003104 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Therapy for the Treatment of Rosacea
NCT00945373 ·Status: COMPLETED ·Phase: PHASE1
-
AGN-199201 for the Treatment of Erythema With Rosacea
NCT01735201 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias
NCT02761174 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea
NCT03380390 ·Status: COMPLETED ·Phase: PHASE4
-
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
NCT02616250 ·Status: COMPLETED ·Phase: PHASE4
-
Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea
NCT06033352 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Patients With Blepharitis and Facial Rosacea
NCT00560703 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients
NCT02052999 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea
NCT07343635 ·Status: RECRUITING ·Phase: NA
-
A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea
NCT01614743 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome
NCT01917539 ·Status: WITHDRAWN ·Phase: NA
-
A Twelve Week Safety and Efficacy Study in Rosacea
NCT01784133 ·Status: COMPLETED ·Phase: PHASE2
-
Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea
NCT00483145 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety and Efficacy of Topical Roflumilast Cream in the Treatment of Facial Papulopustular Rosacea
NCT05278624 ·Status: COMPLETED ·Phase: PHASE2